These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 27803135

  • 21. Complete and sustained resolution of calcinosis universalis in a juvenile dermatomyositis case with mycophenolate mofetil.
    Çakan M, Karadağ ŞG, Ayaz NA.
    Turk J Pediatr; 2019; 61(5):771-775. PubMed ID: 32105011
    [Abstract] [Full Text] [Related]

  • 22. Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety.
    Al-Mayouf SM, Laxer RM, Schneider R, Silverman ED, Feldman BM.
    J Rheumatol; 2000 Oct; 27(10):2498-503. PubMed ID: 11036850
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The clinical features of juvenile dermatomyositis: A single-centre inception cohort.
    Cancarini P, Nozawa T, Whitney K, Bell-Peter A, Marcuz JA, Taddio A, Guo J, Dover S, Feldman BM.
    Semin Arthritis Rheum; 2022 Dec; 57():152104. PubMed ID: 36183479
    [Abstract] [Full Text] [Related]

  • 25. Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference.
    Huber AM, Robinson AB, Reed AM, Abramson L, Bout-Tabaku S, Carrasco R, Curran M, Feldman BM, Gewanter H, Griffin T, Haines K, Hoeltzel MF, Isgro J, Kahn P, Lang B, Lawler P, Shaham B, Schmeling H, Scuccimarri R, Shishov M, Stringer E, Wohrley J, Ilowite NT, Wallace C, Juvenile Dermatomyositis Subcommittee of the Childhood Arthritis and Rheumatology Research Alliance.
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):546-53. PubMed ID: 22076847
    [Abstract] [Full Text] [Related]

  • 26. Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey.
    Shenoi S, Nanda K, Schulert GS, Bohnsack JF, Cooper AM, Edghill B, Gillispie-Taylor MC, Goldberg B, Halyabar O, Mason TG, Ronis T, Schneider R, Vehe RK, Onel K, Childhood Arthritis and Rheumatology Research Alliance Systemic Juvenile Idiopathic Arthritis Workgroup.
    Pediatr Rheumatol Online J; 2019 Jul 22; 17(1):48. PubMed ID: 31331351
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis.
    Aslanidis S, Pyrpasopoulou A, Kartali N, Zamboulis C.
    Clin Rheumatol; 2007 Jul 22; 26(7):1198-200. PubMed ID: 16779504
    [Abstract] [Full Text] [Related]

  • 29. Favorable outcome of juvenile dermatomyositis treated without systemic corticosteroids.
    Levy DM, Bingham CA, Kahn PJ, Eichenfield AH, Imundo LF.
    J Pediatr; 2010 Feb 22; 156(2):302-7. PubMed ID: 19846111
    [Abstract] [Full Text] [Related]

  • 30. Update on the clinical management of juvenile dermatomyositis.
    Huber AM.
    Expert Rev Clin Immunol; 2018 Dec 22; 14(12):1021-1028. PubMed ID: 30308133
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists.
    Li SC, Feldman BM, Higgins GC, Haines KA, Punaro MG, O'Neil KM.
    J Rheumatol; 2010 Jan 22; 37(1):175-81. PubMed ID: 19918041
    [Abstract] [Full Text] [Related]

  • 33. Treatment of polymyositis and dermatomyositis.
    Kaye SA, Isenberg DA.
    Br J Hosp Med; 2010 Jan 22; 52(9):463-8. PubMed ID: 7874361
    [Abstract] [Full Text] [Related]

  • 34. The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
    Giancane G, Lavarello C, Pistorio A, Oliveira SK, Zulian F, Cuttica R, Fischbach M, Magnusson B, Pastore S, Marini R, Martino S, Pagnier A, Soler C, Staņēvicha V, Ten Cate R, Uziel Y, Vojinovic J, Fueri E, Ravelli A, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO).
    Pediatr Rheumatol Online J; 2019 May 22; 17(1):24. PubMed ID: 31118099
    [Abstract] [Full Text] [Related]

  • 35. Comparison of treatments and outcomes of children with juvenile dermatomyositis followed at two European tertiary care referral centers.
    Varnier GC, Consolaro A, Maillard S, Pilkington C, Ravelli A.
    Rheumatology (Oxford); 2021 Nov 03; 60(11):5419-5423. PubMed ID: 33528490
    [Abstract] [Full Text] [Related]

  • 36. Rapid and sustained response to JAK inhibition in a child with severe MDA5 + juvenile dermatomyositis.
    Strauss T, Günther C, Schnabel A, Wolf C, Hahn G, Lee-Kirsch MA, Brück N.
    Pediatr Rheumatol Online J; 2023 Sep 19; 21(1):104. PubMed ID: 37726751
    [Abstract] [Full Text] [Related]

  • 37. Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA).
    Orandi AB, Baszis KW, Dharnidharka VR, Huber AM, Hoeltzel MF, CARRA Juvenile Myositis subgroup.
    Pediatr Rheumatol Online J; 2017 Sep 21; 15(1):71. PubMed ID: 28934971
    [Abstract] [Full Text] [Related]

  • 38. Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.
    Li SC, Fuhlbrigge RC, Laxer RM, Pope E, Ibarra MF, Stewart K, Mason T, Becker ML, Hong S, Dedeoglu F, Torok KS, Rabinovich CE, Ferguson PJ, Punaro M, Feldman BM, Andrews T, Higgins GC, CARRA Registry Investigators.
    Pediatr Rheumatol Online J; 2019 Jul 15; 17(1):43. PubMed ID: 31307476
    [Abstract] [Full Text] [Related]

  • 39. Juvenile dermatomyositis in Thai children: Retrospective review of 30 cases from a tertiary care center.
    Nitiyarom R, Charuvanij S, Likasitwattanakul S, Thanoophunchai C, Wisuthsarewong W.
    Indian J Dermatol Venereol Leprol; 2022 Jul 15; 88(2):162-170. PubMed ID: 34491668
    [Abstract] [Full Text] [Related]

  • 40. Comparison of clinical and laboratory features and treatment responses in patients with clinically amyopathic juvenile dermatomyositis and classical juvenile dermatomyositis.
    Gezgin Yıldırım D, Baglan E, Güngörer V, Yıldız C, Tuncez S, Bülbül M, Acar B, Bakkaloğlu SA.
    Int J Rheum Dis; 2023 Aug 15; 26(8):1504-1511. PubMed ID: 37288472
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.